Jay S. Duker
, MD, Director of the New England Eye Center
, discusses the characteristics and complications of age-related macular degeneration
as well as the evolution of treatments for AMD, including the development of anti-VEGF therapies
in the last 6 years.
Consulting Fees: Novartis, QLT, EMD Serono, ThromboGenics, Optos
Contracted Research: Carl Zeiss Meditec, Optovue
Ownership Interest: EyeNetra, Hemera, Ophthotech, Paloma